Topics

AIM ImmunoTech Inc: AIM ImmunoTech Issues Stockholder Update and Details Its Expectations for 2020

06:32 EST 4 Dec 2019 | FinanzNachrichten

OCALA, FL / ACCESSWIRE / December 4, 2019 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers a...

Original Article: AIM ImmunoTech Inc: AIM ImmunoTech Issues Stockholder Update and Details Its Expectations for 2020

NEXT ARTICLE

More From BioPortfolio on "AIM ImmunoTech Inc: AIM ImmunoTech Issues Stockholder Update and Details Its Expectations for 2020"

Quick Search